Transforming growth factor β1 stimulates contrasting responses in metastatic versus primary mouse prostate cancer-derived cell lines in vitro

Cancer Research

Volumn 56, Issue 14, 1996, Pages 3359-3365

  Sehgal, Inder ^a   Baley, Patricia A ^a   Thompson, Timothy C ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CONTROLLED STUDY; DISEASE COURSE; EXTRACELLULAR MATRIX; LUNG METASTASIS; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN FAMILY;

ANIMALS; CELL DIVISION; COLLAGENASES; ENZYME INDUCTION; GELATINASES; GENES, MYC; GENES, P53; GENES, RAS; LUNG NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; MICE; MICE, KNOCKOUT; MOLECULAR WEIGHT; NEOPLASM METASTASIS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROSTATIC NEOPLASMS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0030002175     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Roberts, A. B., and Sporn, M. B. The transforming growth factor-betas In. M. B. Sporn and A. B. Roberts (eds.), Handbook of Experimental Pharmacology; Peptide Growth Factors and Their Receptors I, Vol. 95, pp. 417-472. Berlin: Springer-Verlag, 1990.
2. Lawrence, D. A , Pircher, R., and Jullien, P. Conversion of a high molecular weight latent β-TGF from chicken, embryo fibroblasts into a low molecular weight active β-TGF under acidic conditions. Biochem. Biophys. Res. Commun., 133: 1026-1034, 1985.
3. Chen, R , Ebner, R., and Derynck, R. Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-β activities. Science (Washington DC), 260: 1335-1338, 1993
4. Bassing, C. H , Yingling, J. M., Howe, D. J., Wang, T., He, W. W., Gustafson, M. L., Shah, P., Donahoe, P. K., and Wang X. A transforming growth factor β type I receptor that signals to activate gene expression. Science (Washington DC), 263: 87-89, 1994.
5. ten Dijke, P., Yamashita, H., Ichijo, H., Franzen, P., Laiho, M., Miyazono, K., and Heldin, C. Characterization of type I receptors for transforming growth factor-β and activin. Science (Washington DC), 264: 101-104, 1994
6. Miettinen, P. J., Ebner, R., Lopez, A. R., and Derynck, R. TGF-β induced transdifferentiation of mammary epithelial cells to mesenchymal cells, involvement of type I receptors. J. Cell Biol., 127: 2021-2036, 1994.
7. Ebner, R., Chen, R., Shum, L., Lawler, S , Zioncheck, T. F., Lee, A., Lopez, A R., and Derynck, R. Cloning of a type I TGF-β receptor and its effect on TGF-β binding to the type II receptor. Science (Washington DC), 260: 1344-1348, 1993.
8. Miyazono, K., Thyberg, J., and Heldin, C-H Retention of the transforming growth factor-β1 precursor in the Golgi complex in a latent endoglycosidase H-sensitive form. J. Biol. Chem., 267: 5668-5675, 1992.
9. Lyons, R. M., Gentry, L. E., Purchio, A F , and Moses, H L. Mechanism of activation of latent recombinant transforming growth factor β1 by plasmin. J. Cell Biol , 110: 1361-1367, 1990.
10. Kip1, a cyclin-cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 8: 9-22, 1994.
11. Sodex, J., and Overall, C. M. Matrix metalloproteinases in periodontal tissue remodelling. Matrix, 1 (Suppl): 352-362, 1992
12. Matrisian, L. M., Ganser, G L., Kerr, L. D., Pelton, R W., and Wood, L. D Negative regulation of gene expression by TGF-β. Mol. Reprod. Dev., 32: 111-120, 1992.
13. Kimchi, A., Wang, X-F., Weinberg, R A., Cheifetz, S , and Massague, J. Absence of TGF-β receptors and growth inhibitory responses in retinoblastoma cells. Science (Washington DC), 240: 196-198, 1988.
14. Haddow, S , Fowlis, D. J., Parkinson, K., Akhurst R. J., and Balmin, A Loss of growth control by TGF-β occurs at a late stage of mouse skin carcinogenesis and is independent of ras gene activation. Oncogene, 6: 1465-1470, 1991.
15. Park, K., Kim, S-J., Bang, Y-J., Park, J-G., Kim, N K., Roberts, A B., and Sporn, M. B. Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β. Proc. Natl. Acad. Sci. USA, 91: 8772-8776, 1994.
16. Stearns, M. E., and Stearns, M. Autocnne factors, type IV collagenase secretion and prostatic cancer cell invasion. Cancer Metastasis Rev., 12: 39-52, 1993.
17. Liotta, L. A., Steeg, P A., and Stetler-Stevenson, W G. Cancer metastasis and angiogenesis, an imbalance of positive and negative regulation. Cell, 64: 327-336, 1991.
18. Bernhard, E J., Gruber, S. B., and Muschel, R. J. Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc. Natl. Acad. Sci. USA, 91: 4293-4297, 1994.
19. Welch, D. R., Fabra, A., and Nakajima, M. Transforming growth factor β stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proc. Natl. Acad Sci USA, 87: 7678-7682, 1990
20. Samuel, S. K., Hurta, R A R., Kondaiah, P., Khalil, N., Turley, E. A , Wnght, J. A., and Greenberg, A. H. Autocrine induction of tumor protease production and invasion by a metallothionein-regulated TGF-β1 (Ser 223, 225). EMBO J , 11: 1599-1605, 1992.
21. Chang, H-L., Gillett, N., Figari, I , Lopez, A. R., Palladino, M. A., and Derynck, R. Increased transforming growth factor β expression exhibits cell proliferation in vitro, yet increases tumorigenicity and tumor growth of Meth A sarcoma cells. Cancer Res., 53 4391-4398, 1993
22. Steiner, M. S , and Barrack, E. R Transforming growth factor-β1 overproduction in prostate cancer: effects on growth in vivo and in vitro. Mol Endocrinol. 6: 15-25, 1992.
23. Contractor, H. E , Morton, D. M., and Barrack, E. R. Enhancement of metastatic potential and motility of prostate cancer cells by transforming growth factor β1. Proc Am. Assoc. Urol., 153 281 A, 1995
24. Donehower, L. A., Harvey, M , Slagle, B. L., McArthur, M. J., Montgomery, C A., Butel, J. S., and Bradley, A Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature (Lond.) 356 215-221, 1992
25. Thompson, T. C , Park, S. H., Timme, T. L., Ren, C., Eastham, J., Donehower, L , Bradley, A , Kadmon, D., and Yang, G. Loss of p53 function leads to metastasis in ras + myc-initiated mouse prostate cancer. Oncogene, 10: 869-879, 1995.
26. Weiss, L. Comments on hematogenous metastatic patterns in humans as revealed by autopsy. Clin. Exp. Metastasis, 10: 191-199, 1992.
27. Thompson, T., Southgate, J., Kitchener, G., and Land, H. Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ. Cell, 56: 917-930, 1989
28. Danielpour, D., Dart, L. L , Flanders, K. C., Roberts, A B., and Sporn, M. B. Immunodetection and quantitation of the two forms of transforming growth factor-beta (TGF-β 1 and TGF-β 2) secreted by cells in culture. J. Cell. Physiol., 138: 79-86, 1989.
29. Frolik, C. A., Wakefield, L. M., Smith, D. M., and Sporn, M. B. Characterization of a membrane receptor for transforming growth factor-β in normal rat kidney fibroblasts J Biol Chem , 259: 10995-11000, 1984
30. Massague, J. Identification of receptors for type-β transforming growth factor. Methods Enzymol., 146: 174-195, 1985
31. Laiho, M , Ronnstrand, L., Heino, J., DeCaprio, J. A, Ludlow, J. W., Livingston, D. M , and Massague, J. Control of JunB and extracellular matrix protein expression by transforming growth factor β1 is independent of simian virus 40 T antigen-sensitive growth-inhibitory events Mol Cell. Biol., 11: 972-978, 1991.
32. Himelstein, B. P., Soler, R. C , Bernhard, E. J., and Muschel, R. J. Induction of fibroblast 92 kDa gelatinase/type IV collagenase expression by direct contact with metastatic tumor cells. J Cell Sci., 107: 1-10, 1994.
33. Tanaka, H., Hojo, K., Yoshida, H., Yoshtoka, T., and Sugita, K Molecular cloning and expression of the mouse 105-kDa gelatmase cDNA. Biochem. Biophys. Res. Commun. 190 732-740, 1993.
34. Reponen, P., Sahlberg, C., Munaut, C., Thesleff, I., and Tryggvason, K High expression of 92-kDa type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development. J. Cell Biol., 124: 1091-1102, 1994.
35. Marti, H. P., Lee, L., Kashgarian, M., and Lovett, D. H Transforming growth factor-β1 stimulates glomerular mesangial cell synthesis of the 72-kd type IV collagenase. Am. J. Pathol., 144: 82-94, 1994.
36. Nicolson, G. L. Organ specificity of tumor metastasis: role of preferential adhesion, invasion, and growth of malignant cells at specific secondary sites. Cancer Metastasis Rev., 7: 143-188, 1988.
37. Fidler, I. J. Critical factors in the biology of human cancer metastasis: Twenty-Eighth G. H. A. Clowes Memorial Award Lecture. Cancer Res , 50: 6130-6138, 1990
38. Kerbel, R. S. Growth dominance of the metastatic cancer cell: cellular and molecular aspects. Adv Cancer Res., 55: 87-132, 1990.
39. Theodorescu, D., Caltabiano, M , Grieg, R., Rieman, D., and Kerbel, R. S. Reduction of TGF-beta activity abrogates growth promoting tumor cell-cell interactions in vivo. J. Cell. Physiol., 148: 380-390, 1991.
40. Weinstat-Saslow, D., and Steeg, P S. Angiogenesis and colonization in the tumor metastatic process: basic and applied advances. FASEB J , 8: 401-406, 1994.
41. Markowitz, S., Wang, J , Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K W., Vogelstein, B , Brattain, M., and Willson, J. K. V. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science (Washington DC), 268: 1336-1338, 1995.
42. Park, K., Kim, S-J., Bang, Y-J., Park, J-G., Kim, N. K, Roberts, A. B , and Sporn, M. B. Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β. Proc. Natl. Acad Sci USA. 91: 8772-8776, 1994.
43. McKeehan, W. L., and Adams, P. S. Heparin-binding growth factor/prostatropin attenuates inhibition of rat prostate tumor epithelial cell growth by transforming growth factor type beta. In Vitro Cell. Dev. Biol., 24: 243-246, 1988.
44. Morton, D. M., and Barrack, E. R. Modulation of transforming growth factor β1 effects on prostate cancer cell proliferation by growth factors and extracellular matrix. Cancer Res , 55: 2596-2602, 1995.
45. Xu, J., Matsuzaki, K., McKeehan, K., Wang. F., Kan, M., and McKeehan, W. Gcnomic structure and cloned cDNAs predict that four variants in the kinase domain of serine/threonine kinase receptors arise by alternative splicing and poly(A) addition. Proc. Natl Acad. Sci. USA. 91: 7957-7961, 1994.
46. cdc2, and this effect is abrogated by adenovirus independently of the EIA-associated pRB binding activity. Mol. Biol. Cell. 3: 655-665, 1992.
47. Attisano, L., Wrana, J., Casillas, F L , and Massague. J TGF-β receptors and actions. Biochim. Biophys. Acta, 1222: 71-80, 1994
48. ink4B is a potential effector of TGF-β-induced cell cycle arrest. Nature (Lond), 371: 257-261, 1994.
49. Matrisian, L M. Metalloproteinases and their inhibitors in tissue remodeling. Trends Genet., 6: 121-125, 1990
50. Samuel, S K , Hurta, R A. R., Kondaiah, P , Khalil, N., Turley, E A., Wright, J A , and Greenberg, A. H. Autocrine induction of tumor protease production and invasion by a metallothionein-regulated TGF-β1 (Ser 223, 125) EMBO J., 11: 1599-1605, 1992.
51. Fridman, R., Toth, M , Pena, D., and Mobashery, S Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2) Cancer Res , 55: 2548-2555, 1995.
52. Taipale, J., Miyazono, K , Heldin, C-H , and Keski-Oja, J. Latent transforming growth factor-β1 associates to fibroblast extracellular matrix via latent TGF-β binding protein. J. Cell Biol., 124 171-181, 1994.
53. Wakefield, L M , Kim, S-J., Glick, A., Winokur, T., Colletta, A., and Sporn, M. B. Regulation of transforming growth factor-beta subtypes by members of the steroid hormone superfamily. J. Cell Sci. Suppl., 13: 139-148, 1990.
54. Bodmer, S. Strommer, K., Frei, K., Siepl, C , DeTribolet, N., Heid, I., and Fontana, A Immunosuppression and transforming growth factor-beta in glioblastoma. Preferential production of transforming growth factor-beta 2. J Immunol , 143: 3222-3229, 1989.
55. Nicolson, G L. Paracrine and autocrine growth mechanisms in tumor metastasis to specific sites with particular emphasis on brain and lung metastasis. Cancer Metastasis Rev., 12: 325-343, 1993